The Global Health Body Sounds Warning Over Severe Shortage of Obesity Jabs
Less than 10% of patients eligible to benefit from GLP-1 drugs including Wegovy can access them, warns the World Health Organization as it issues its initial recommendations on the drugs.
With in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for more widespread and fairer availability to these injectable treatments.
According to estimates, over two billion will be living with obesity by 2030 without intervention.
"Our new guidelines recognises that obesity is a lifelong illness that can be managed with thorough and lifelong support," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and supply-chain constraints are key barriers to universal access to the jabs that can assist patients in reducing significant weight, notes the body.
Skinny Jab Scarcity
Even under the present best projected case, the manufacturing of these medications could only cover approximately 100 million people – less than 10% of eligible patients, as stated by the WHO.
The advice encourages nations and manufacturers to increase access, by approaches like patent sharing.
The intellectual property rights on semaglutide – the core component of a leading brand – is due to expire in several nations in 2026.
The Way Weight-Loss Injections Work
GLP-1 drugs replicate a natural hormone to reduce digestion speed, curb appetite and increase feelings of fullness so people consume fewer calories.
Individuals commonly begin shedding pounds in the initial weeks of commencing the regular doses.
Research indicates users may put most of the weight back on a year later of discontinuing the drug, when their typical food cravings come back.
To be above a healthy weight increases your risk for experiencing health problems, such as type 2 diabetes, heart disease, brain attack, and certain cancers.
Excess weight impacts individuals in countries worldwide and was associated with 3.7 million deaths worldwide in 2024, as per the health agency.
